Skip to content

The Effect of Intranasal Dexmedetomidine Premedication on the Minimum Alveolar Concentration of Sevoflurane for the Insertion of Laryngeal Mask Airway in children

The Effect of Intranasal Dexmedetomidine Premedication on Reducing the Minimum Alveolar Concentration of Sevoflurane for the Insertion of Laryngeal Mask Airway in Children

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12613000462785
Enrollment
90
Registered
2013-04-23
Start date
2013-05-13
Completion date
2013-11-28
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Sevoflurane is widely employed for inhalational induction of general anaesthesia in children. There is increasing evidence that dexmedetomidine is an effective and safe sedative in children. Laryngeal mask airway is an useful device for pediatric anesthesia. The aim of the current study was to determine whether Intranasal dexmedetomidine premedication can reduce MAC of sevoflurane for an LMA insertion in children

Interventions

GroupD1 received 1mcg/Kg intranasal dexmedetomidine premedication 45min before general anaesthesia; GroupD2 received 2mcg/Kg intranasal dexmedetomidine premedication 45min before general anaesthesia;the intervention and the participants will be monitored throughout the duration of the procedure with follow up ending 4 hours after the procedure has been completed

Sponsors

Yusheng Yao
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
3 Years to 7 Years
Healthy volunteers
No

Inclusion criteria

ASA 1 and 2 patients of either gender of the age 3- 7 years undergoing elective strabismus surgery under general anaesthesia which can be performed with LMA insertion

Exclusion criteria

Exclusion criteria: airway malformations, clinical evidence of patients with difficult airway, asthma or any sign of upper respiratory tract infection.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026